A new strategy for prevention of liver cancer development

November 14, 2017, University of California - San Diego
Cells treated with a chemical carcinogen show severe liver cancer development. In cells treated with the same dosage of a chemical carcinogen and given synthetic dsRNA treatment at the pre-cancer stage tumor suppression occurred. Credit: UC San Diego Health

Primary liver cancer is now the second leading cause of cancer-related death worldwide, and its incidences and mortality are increasing rapidly in the United Stated. In late stages of the malignancy, there are no effective treatments or drugs. However, an unexpected finding made by a team of University of California San Diego School of Medicine researchers sheds light on the development of a new strategy for prevention of liver cancer.

While studying the pathogenic mechanisms of , the researchers discovered that a commonly used synthetic double-stranded RNA (dsRNA) strongly boosts a variety of anti-tumor innate immune functions. They suggest it may have the potential to be administered as a vaccine to prevent in individuals at high-risk of developing cancer.

"The liver has unique immune tolerance, which is why existing treatments, including immunotherapy, have little to no lasting effects on liver cancer," said Gen-Sheng Feng, PhD, professor of pathology and molecular biology at UC San Diego and senior author on the paper. "We were initially performing gene deletion to investigate how different types of communicate in the liver to promote or suppress cancer development when we found that this synthetic double-stranded RNA prevented liver cancer from initiating by harnessing the body's own innate immune system."

In the findings, published online on November 14 in Cell Reports, researchers describe how dsRNA polyinosinic-polycytidylic acid (pIC) prevented primary liver cancer from occurring in mouse models when it was injected into the body cavity during the pre-cancer stage. Primary liver cancer is cancer that begins in the liver; metastatic liver cancer starts elsewhere in the body and spreads to the liver.

The study showed that the formation of tumors—or tumorigenesis—was suppressed by reprogramming macrophages (specialized immune cells that destroy targeted cells) and activation of natural killer cells and dendritic cells that kill tumor cells directly or boost adaptive immunity.

Mouse models with tumors induced either by chemical carcinogen or fatty liver diseases were injected with pIC at different stages. Tumor inhibition was successful in all models that received the dsRNA before . The greatest decrease in tumor numbers and size was seen when pIC was administered at one month. At three months the impact was reduced but still significant. At five months, when tumors had already began to form, there was little inhibitory effect observed when comparing tumor numbers or sizes to control groups.

Future studies will look at dosages and timing of pIC as a vaccine, said Feng. In addition, the researchers will evaluate the use of pIC in combination with other agents to stop tumor growth when cancer has already initiated.

"The findings suggest that the drug may prevent liver cancer. We have more work to do, but we could make a real impact at a time when liver cancer rates are increasing," said Feng, also a researcher with UC San Diego Moores Cancer Center. "There is a large population living with who are at high risk of developing cancer. If we can develop a vaccine that prevents formation or a therapeutic combination that stops existing cancer from growing, we could reduce the rapid increase of liver cancer rates."

Liver cancer in adults is among the leading causes of cancer mortality in the world, with more than 780,000 new cases and 740,000 deaths each year. More than 40,000 new cases are diagnosed and 29,000 deaths are reported in the United States annually.

Explore further: How chronic inflammation tips the balance of immune cells to promote liver cancer

More information: Cell Reports (2017). DOI: 10.1016/j.celrep.2017.10.064

Related Stories

How chronic inflammation tips the balance of immune cells to promote liver cancer

November 8, 2017
Chronic inflammation is known to drive many cancers, especially liver cancer. Researchers have long thought that's because inflammation directly affects cancer cells, stimulating their division and protecting them from cell ...

Team finds a potentially better way to treat liver cancer

October 12, 2017
A Keck School of Medicine of USC research team has identified how cancer stem cells survive. This finding may one day lead to new therapies for liver cancer, one of the few cancers in the United States with an incidence rate ...

Global burden of disease study focuses on liver cancer

October 5, 2017
A new article published by JAMA Oncology reports the results of the Global Burden of Disease 2015 study on primary liver cancer incidence, death and years of healthy life lost in 195 countries or territories from 1990 to ...

Study identifies a role for the metabolism regulator PPAR-gamma in liver cancer

April 10, 2017
Liver cancers are a major cause of cancer-related deaths. Large-scale genetic analyses have associated liver cancer with dysregulation of numerous molecular pathways, but disruptions in insulin signaling pathways appear to ...

Can aspirin stop liver cancer in hepatitis B patients?

October 20, 2017
(HealthDay)—Daily aspirin may reduce the risk of liver cancer for people with hepatitis B infection, a new study suggests.

Monitoring sugar metabolism in liver may be a key to cancer diagnosis

April 18, 2016
Scientists may have discovered a significant new diagnostic marker for liver cancer, according to a paper published in the April 18 online issue of Nature Cell Biology.

Recommended for you

Researchers create a drug to extend the lives of men with prostate cancer

March 16, 2018
Fifteen years ago, Michael Jung was already an eminent scientist when his wife asked him a question that would change his career, and extend the lives of many men with a particularly lethal form of prostate cancer.

Machine-learning algorithm used to identify specific types of brain tumors

March 15, 2018
An international team of researchers has used methylation fingerprinting data as input to a machine-learning algorithm to identify different types of brain tumors. In their paper published in the journal Nature, the team ...

Higher doses of radiation don't improve survival in prostate cancer

March 15, 2018
A new study shows that higher doses of radiation do not improve survival for many patients with prostate cancer, compared with the standard radiation treatment. The analysis, which included 104 radiation therapy oncology ...

Joint supplement speeds melanoma cell growth

March 15, 2018
Chondroitin sulfate, a dietary supplement taken to strengthen joints, can speed the growth of a type of melanoma, according to experiments conducted in cell culture and mouse models.

Improved capture of cancer cells in blood could help track disease

March 15, 2018
Tumor cells circulating throughout the body in blood vessels have long been feared as harbingers of metastasizing cancer - even though most free-floating cancer cells will not go on to establish a new tumor.

Area surrounding a tumor impacts how breast cancer cells grow

March 14, 2018
Cancer is typically thought of as a tumor that needs to be removed or an area that needs to be treated with radiation or chemotherapy. As a physicist and cancer researcher, Joe Gray, Ph.D., thinks differently.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

1 / 5 (1) Nov 15, 2017
.... there are no effective treatments or drugs. Of course there aren't. The 1939 UK Cancer Act prohibits the publication of any cancer cure. In the US the Med Js refuse to publish ie Dr R Good's 1985 natural pancreatic cancer cure, Dr. Good made the 1st bone marrow transplant and had 2000+ Med. papers out. (Cancer is a 1/3T$ Industry)! H R Clark, PhD ND carried out over 1/2million reproducible bio-resonance tests to precisely identify the causes an pathways of all cancers. .Privately published is her The Cure and Prevention of All Cancers, 2007, 600pages.

Existing cures interrupt the pathways Dr Clark discovered. cure most and prevent 98%. with Clark's protocols; Electronic zappers of Drs. Clark, Beck Rife; Herbals of essiac, Hoxey's, Jason Winters', Sunderandia, cannabis oil, papaya leaf; Germany's ozone, Vit D3, etc. Clark advises use many different ones as causes are specific parasites, viruses, bacteria, heavy metals. molds, radio-active compounds benzene, asbestos et

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.